NOVARTIS is once again being
sued by the US government,
with a civil case filed earlier
this week accusing the Swiss
drugmaker of causing the US
Medicare and Medicaid programs
to pay tens of millions of dollars
in reimbursements based on
fraudulent claims.
The lawsuit alleges that Novartis
induced at least 20 pharmacies to
switch kidney transplant patients
to its Myfortic immunosuppressant
drug from competitor medications,
in exchange for “kickbacks
disguised as rebates and discounts”.
“Novartis co-opted the
independence of certain
pharmacists and turned them into
salespeople,” said US Attorney
Preet Bhahara in New York.
Last year Myfortic sales were
worth $579 million to Novartis, an
increase of 12%.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Apr 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Apr 13
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.